Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)
China flag China · Delayed Price · Currency is CNY
12.02
-0.11 (-0.91%)
Nov 17, 2026, 3:00 PM CST

SHA:600161 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
5,5556,1686,0325,1804,2614,112
Revenue Growth
-13.52%2.26%16.43%21.57%3.63%19.35%
Gross Profit
2,0822,6773,2872,6282,0891,954
Operating Income
1,2091,7812,4721,7061,2931,174
Net Income
700.141,0911,5491,110880.92760.01
Earnings Per Share
0.360.550.780.560.440.39
EPS Growth
-45.42%-29.49%39.29%26.78%12.77%10.73%

Revenue by Geography

Fiscal Year
FY 2025
Period EndingDec '25
Overseas
1.62
China
6,148
Total
6,150

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,9011,9912,6864,5553,7134,330
Total Debt
79.25160.8253.8242.37403.17508.92
Net Cash (Debt)
1,8221,8302,6324,5133,3103,821
Net Cash Growth
9.33%-30.46%-41.68%36.34%-13.38%303.40%
Net Cash Per Share
0.940.921.332.281.661.97

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
632.02338.75819.782,3941,126980.35
Capital Expenditures
-619.41-605.53-1,067-1,078-1,354-1,132
Free Cash Flow
12.61-266.78-247.631,316-228.02-151.35
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
37.47%43.41%54.49%50.72%49.02%47.51%
Operating Margin
21.77%28.87%40.98%32.93%30.34%28.55%
Pretax Margin
22.07%29.55%42.23%34.72%33.47%30.18%
Profit Margin
12.60%17.69%25.68%21.43%20.67%18.48%
FCF Margin
0.23%-4.32%-4.11%25.40%-5.35%-3.68%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.2000.2000.1000.1250.0420.069
Dividend Per Share Growth
-40.00%100.00%-20.00%199.76%-39.91%0%
Dividend Yield
1.66%1.22%0.49%0.48%0.21%0.34%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
33.3929.6226.1745.9444.3952.33
Forward PE
25.0419.5729.4839.6339.1445.04
P/FCF Ratio
1885.29--38.74--
PS Ratio
4.285.246.729.849.189.67